Insider filing · TRDA
Natarajan Sethuraman
President, Research & Develop.
profile →
Entrada Therapeutics, Inc.
TRDA · Healthcare · 31 filings in 24 months
ticker →
Natarajan Sethuraman sold $399K of Entrada Therapeutics (TRDA)
Executed May 4, disclosed May 4, the same day.
Value, as filed
$399K
25,907 sh × $15.39
Executed
May 4
the trade date, as filed
Disclosed
May 4
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NSNatarajan Sethuraman (President, Research & Develop.) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Entrada Therapeutics, Inc. (TRDA). The largest single filing was $399K of TRDA (25,907 sh × $15.39, as filed), executed May 4.
The name
TRDAHealthcare · Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new c…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Natarajan Sethuraman in TRDA
TRDASALE
Entrada Therapeutics, Inc.
$236K11,703 sh × $20.15
Exec Dec 3 2024
Filed Dec 3 2024 · 5:30 PM ET TRDASALE Entrada Therapeutics, Inc. $179K
9,554 sh × $18.71
Exec Nov 6 2024
Filed Nov 6 2024 · 5:30 PM ET